Antisense oligonucleotide treatment of inflammatory bowel diseases.
Yacyshyn
Bruce R
BR
Louis Stokes VA Hospital and Case Western Reserve University, Cleveland, OH, USA.
D019540:Area Under Curve; D002986:Clinical Trials as Topic; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D008297:Male; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology / Q000627:therapeutic use; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D054735:Phosphorothioate Oligonucleotides; D013873:Thionucleotides / Q000494:pharmacology / Q000627:therapeutic use
D005765:Gastrointestinal Agents; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense; D054735:Phosphorothioate Oligonucleotides; D013873:Thionucleotides; C089753:alicaforsen